Abrdn Life Sciences Investors (HQL) To Go Ex-Dividend on February 21st

Abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Tuesday, February 11th,Wall Street Journal reports. Investors of record on Friday, February 21st will be given a dividend of 0.47 per share on Monday, March 31st. This represents a $1.88 dividend on an annualized basis and a dividend yield of 13.28%. The ex-dividend date of this dividend is Friday, February 21st.

Abrdn Life Sciences Investors Stock Up 1.2 %

HQL opened at $14.16 on Wednesday. The business has a 50 day moving average price of $13.73 and a two-hundred day moving average price of $14.49. Abrdn Life Sciences Investors has a 52 week low of $12.76 and a 52 week high of $15.90.

Insider Buying and Selling

In related news, major shareholder Saba Capital Management, L.P. sold 15,143 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $14.27, for a total value of $216,090.61. Following the completion of the sale, the insider now owns 3,381,371 shares in the company, valued at $48,252,164.17. This trade represents a 0.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 108,186 shares of company stock valued at $1,508,866 over the last three months. 10.06% of the stock is currently owned by company insiders.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.